CompoAtlas

Fengshi Antai Tablet

Fengshi Antai Tablet : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL12025017T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
TONGHUA DONG BAO (M) SDN. BHD.
Manufacturer
TONGHUA DONGBAO THE 5TH PHARMACEUTICAL CO., LTD
Importer
HBL (M) SDN BHD
Registration period starting
2022-02-25
Published validity end
2027-02-25

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Notopterygium incisumNotopterygium incisum[13.2mg;280mg]Not identified
Carthamus tinctoriusCarthamus tinctorius[13.2mg;280mg]Not identified
Drynaria fortuneiDrynaria fortunei[13.2mg;280mg]Not identified
Prunus mumePrunus mume[13.2mg;280mg]Not identified
Ginseng rubraGinseng rubra[13.2mg;280mg]Not identified
Phellodendron chinensePhellodendron chinense[13.2mg;280mg]Not identified
Commiphora myrrhaCommiphora myrrha[13.2mg;280mg]Not identified
ILLICIUM DEFENGPIILLICIUM DEFENGPI[13.2mg;280mg]Not identified
Acanthopanax grasilistylusAcanthopanax grasilistylus[13.2mg;280mg]Not identified
Dipsacus asperDipsacus asper[13.2mg;280mg]Not identified
Glycyrrhiza uralensisGlycyrrhiza uralensis[13.2mg;280mg]Not identified
Viscum coloratumViscum coloratum[13.2mg;280mg]Not identified
Lonicera japonicaLonicera japonica[13.2mg;280mg]Not identified
Epimedium brevicornumEpimedium brevicornum[13.2mg;280mg]Not identified
Achyranthes bidentataAchyranthes bidentata[13.2mg;280mg]Not identified
Cinnamomum cassiaCinnamomum cassia[13.2mg;280mg]Not identified
Erodium stephanianumErodium stephanianum[13.2mg;280mg]Not identified
Zaocys dhumnadesZaocys dhumnades[13.2mg;280mg]Not identified
Cornu cervi pantotrichumCornu cervi pantotrichum[8.6mg;280mg]Acide pantothénique (vitamine B5)
Pheretima aspergillumPheretima aspergillum[13.2mg;280mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Notopterygium incisum[13.2mg;280mg],Carthamus tinctorius[13.2mg;280mg],Drynaria fortunei[13.2mg;280mg],Prunus mume[13.2mg;280mg],Ginseng rubra[13.2mg;280mg],Phellodendron chinense[13.2mg;280mg],Commiphora myrrha[13.2mg;280mg],ILLICIUM DEFENGPI[13.2mg;280mg],Acanthopanax grasilistylus[13.2mg;280mg],Dipsacus asper[13.2mg;280mg],Glycyrrhiza uralensis[13.2mg;280mg],Viscum coloratum[13.2mg;280mg],Lonicera japonica[13.2mg;280mg],Epimedium brevicornum[13.2mg;280mg],Achyranthes bidentata[13.2mg;280mg],Cinnamomum cassia[13.2mg;280mg],Erodium stephanianum[13.2mg;280mg],Zaocys dhumnades[13.2mg;280mg],Cornu cervi pantotrichum[8.6mg;280mg],Pheretima aspergillum[13.2mg;280mg]
Valid until
2027-02-25
Registration date
2022-02-25
Published description
NATURAL PRODUCT
Licence holder
TONGHUA DONG BAO (M) SDN. BHD.
Importer
HBL (M) SDN BHD
Producer
TONGHUA DONGBAO THE 5TH PHARMACEUTICAL CO., LTD
Published name
Fengshi Antai Tablet
Published reference
201012300001T
Registration number
MAL12025017T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL12025017T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Glycyrrhiza uralensis
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

  • Cinnamomum cassia
    Read the warning, when it applies and the studies cited

    CASSIA - CINNAMOMUM AROMATICUM

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Appetite loss; Digestive disturbances/Indigestion; Traditional Chinese Medicine claims.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Products providing 1 g or more of branch bark, stem bark and/or trunk bark, per day

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Blumenthal et al. 2000; WHO 1999).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Gardner and McGuffin 2013; Brinker 2010).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Applies to products providing 1 g or more of branch bark, stem bark and/or trunk bark, per day.

    Do not use if you are pregnant (PPRC 2020; Brinker 2010; BHC 2006; Chen and Chen 2004; Blumenthal 2000, 1998).

    6 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Traditional Chinese Medicine claims.

    Do not use if you have excess heat, blood heat or deficiency, or yin-deficient fire (PPRC 2020; Bensky et al. 2004; Chen and Chen 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Gardner and McGuffin 2013; Blumenthal 2000; WHO 1999).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 May 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line